IRCT20210222050452N1招募中3 期
Comparison of the efficacy of ivermectin 1% cream and ketoconazole 2% cream in treatment of facial seborrheic dermatitis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients more than 18 years old
- •Clinical diagnosis of seborrheic dermatitis (erythematous plaques with greasy and yellowish scales on nose, nasolabial fold, forehead, frown lines, cheek and chin)
排除标准
- •?Severe facial seborrheic dermatitis
- •Using antibiotics or immunomodulatory drugs since one month before beginning of the research
- •Using any topical drugs that can affect seborrheic dermatitis since two weeks before beginning of the study
- •Using any oral drugs that can affect seborrheic dermatitis since one month before beginning of the research
- •Human immunodeficiency virus infection
- •Sensitivity to the research drugs constituents
- •Parkinson'sdisease
研究者
相似试验
进行中（未招募）
1 期
Oracea Soolantra association in patients with severe rosaceasevere RosaceaMedDRA version: 20.0Level: PTClassification code 10039218Term: RosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2017-000157-40-HUGalderma R&D SNC270
进行中（未招募）
1 期
Oracea Soolantra association in patients with severe rosaceasevere RosaceaMedDRA version: 20.0Level: PTClassification code 10039218Term: RosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2017-000157-40-CZGalderma R&D SNC270
进行中（未招募）
1 期
Oracea Soolantra association in patients with severe rosaceaEUCTR2017-000157-40-DEGalderma R&D SNC270
进行中（未招募）
1 期
Oracea Soolantra association in patients with severe rosaceasevere RosaceaMedDRA version: 20.0Level: PTClassification code 10039218Term: RosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2017-000157-40-PLGalderma R&D SNC270
已完成
4 期
Oracea Soolantra Association in Participants With Severe RosaceaRosaceaNCT03075891Galderma R&D273